RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Special Access to Medicinal Marijuana for Compassionate Use: Policies and Perspectives in Canada an

Special Access to Medicinal Marijuana for Compassionate Use: Policies and Perspectives in Canada and the US

Posted 01 January 2010

Medical use of marijuana is legal in only a limited number of countries. Even though the legality of its use for therapeutic purposes is an ongoing political and ethical debate, basic and clinical research in this field has burgeoned in the past two decades alone. Since this topic is a cause célèbre, this article is not another polemic on whether marijuana should be legalized, but focuses on the special access programs for medicinal marijuana use available in the US and Canada. Similarities and differences in policies and perspectives between the two neighboring countries are highlighted.

 

© 2022 Regulatory Affairs Professionals Society.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe